Federal Register / Vol. 74, No. 68 / Friday, April 10, 2009 / Notices 16407 

The meeting will be held April 16, 

2009, 4 p.m. to April 17, 2009, 6 p.m. 

The meeting location remains the same. 

The meeting is closed to the public. 

Dated: April 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8019 Filed 4–9–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Statistical and Clinical 

Coordinating Center for Autoimmune Disease 

Clinical Trials. 

Date: April 27, 2009. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Jay Bruce Sundstrom, PhD, 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, Room 

3119, 6700B Rockledge Drvie, MSC–7616, 

Bethesda, MD 20892–7616, 301–496–7042, 

sundstromj@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Evaluation of the Immune 

Response to Novel HIV Vaccine. 

Date: April 29, 2009. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Katrin Eichelberg, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–451–2899, 

keichelberg@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: April 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8210 Filed 4–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; CMBK 

Conflicts. 

Date: April 28, 2009. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ryan G. Morris, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Coagulation 

and Thrombosis. 

Date: April 30–May 1, 2009. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Manjit Hanspal, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1195, hanspalm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; OBT and 

IMM Member Applications. 

Date: May 1, 2009. 

Time: 11 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, Department of Health and Human 

Services, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–435– 

3566, cooperc@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group; Cancer Molecular 

Pathobiology Study Section. 

Date: May 18–19, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Elaine Sierra-Rivera, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1779, riverase@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Central 

Nervous System Intersections of Drug 

Addiction, Chronic Pain and Analgesia. 

Date: May 18, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Churchill Hotel, 1914 

Connecticut Avenue, NW., Washington, DC 

20009. 

Contact Person: Brian Hoshaw, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5181, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1033, hoshawb@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive, 

Sciences Integrated Review Group; 

Integrative and Clinical Endocrinology and 

Reproduction Study Section. 

Date: May 18, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Syed M. Amir, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6172, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1043, amirs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Auditor 

Neuroscience. 

Date: May 27–28, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

16408 Federal Register / Vol. 74, No. 68 / Friday, April 10, 2009 / Notices 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5180, 

MSC 7844, Bethesda, MD 20892, (301) 435– 

1250, bishopj@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated; Review Group 

Gastrointestinal Cell and Molecular Biology 

Study Section. 

Date: May 29, 2009. 

Time: 7 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Avenue Hotel Chicago, 160 E. Huron 

Street, Chicago, IL 60611. 

Contact Person: Najma Begum, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2186, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1243, begumn@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics B Study Section. 

Date: May 31–June 1, 2009. 

Time: 7 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Catamaran Resort Hotel, 3999 

Mission Boulevard, San Diego, CA 92109. 

Contact Person: Richard A. Currie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7840, Bethesda, MD 20892, (301) 435– 

1219, currieri@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8111 Filed 4–9–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

Date: May 5, 2009. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, 6707 Democracy Blvd., 920, 

MSC–5469, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Ruth Grossman, DDS, 

Scientific Review Officer, National Institutes 

of Biomedical Imaging, and Bioengineering, 

6707 Democracy Boulevard, Room 960, 

Bethesda, MD 20892, 301–496–8775, 

grossmanrs@mail.nih.gov. 

Dated: April, 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8110 Filed 4–9–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Solicitation for Nominations for 

Members of the U.S. Preventive 

Services Task Force (USPSTF) 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Solicits nominations for new 

members of USPSTF. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) invites 

nominations of individuals qualified to 

serve as members of the U.S. Preventive 

Services Task Force (USPSTF). 

The USPSTF, a standing, panel of 

outside experts that makes evidencebased recommendations to the health 

care community and the public 

regarding the provision of clinical 

preventive services, is composed of 

members appointed to serve for four 

year terms with an option for 

reappointment. New members are 

selected each year to replace 

approximately one fourth of the 

USPSTF members, i.e., those who are 

completing their appointments. 

Individuals nominated but not 

appointed in previous years, as well as 

those newly nominated, are considered 

in the annual selection process. 

USPSTF members meet three times a 

year for two days in the Washington, DC 

area. Between meetings, member duties 

include reviewing and preparing 

comments (off site) on systematic 

evidence reviews prior to discussing 

and making recommendations on 

preventive services, drafting final 

recommendation documents, and 

participating in workgroups on specific 

topics or methods. 

To obtain a diversity of perspectives, 

and enhance opportunities, AHRQ 

particularly encourages nominations of 

women, members of minority 

populations, and persons with 

disabilities. Interested individuals can 

self nominate. Organizations and 

individuals may nominate one or more 

persons qualified for membership on the 

USPSTF. 

Qualification Requirements: The 

mission of the USPSTF is to produce 

evidence-based recommendations on 

the appropriate screening, counseling, 

and provision of preventive medication 

for asymptomatic patients seen in the 

primary care setting. Therefore, in order 

to qualify for the USPSTF, an applicant 

or nominee must demonstrate the 

following: 

1. Knowledge and experience in the 

critical evaluation of research published 

in peer reviewed literature and in the 

methods of evidence review; 

2. Understanding and experience in 

the application of synthesized evidence 

to clinical decision-making and/or 

policy; 

3. Expertise in disease prevention and 

health promotion; 

4. Ability to work collaboratively with 

peers; and, 

5. Clinical expertise in the primary 

health care of children and/or adults, 

and/or expertise in counseling and 

behavioral interventions for primary 

care patients. 

Some USPSTF members without 

primary health care clinical experience 

may be selected based on their expertise 

in methodological issues such as 

medical decision-making, clinical 

epidemiology, behavioral medicine, and 

health economics. 

Consideration will be given to 

individuals who are recognized 

nationally for scientific leadership 

within their field of expertise. 

Applicants must have no substantial 

conflicts of interest, whether financial, 

professional, or other conflicts, that 

would impair the scientific integrity of 

the work of the USPSTF. 

DATES: All nominations submitted in 

writing or electronically, and received 

by Friday, May 15, 2009, will be 

considered for appointment to the 

USPSTF. 

Nominated individuals will be 

selected for the USPSTF on the basis of